MKI67 and neoplasm: Staining for the proliferation marker Ki-67—expressed in cells during interphase or M-phase of the cell cycle [21]—revealed a slightly, but not significantly, higher percentage of proliferating tumor cells in the treated compared to the untreated group (81.6 ± 3.7% vs. 66.9 ± 11.7%.